Literature DB >> 7022447

Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase.

B Ratzkin, S G Lee, W J Schrenk, R Roychoudhury, M Chen, T A Hamilton, P P Hung.   

Abstract

We have isolated clones of Escherichia coli strain K-12 that contain a hybrid pBR322 plasmid having a 4.2-kilobase insert of a DNA transcript of the mRNA of human plasminogen activator, urokinase. The bacterially produced enzyme has properties similar to those of urokinase from human fetal kidney cells. Both enzymes occur in discrete forms ranging from 32,000 to 150,000 daltons in size. They react with antibody to purified urokinase from human kidney cells, bind to a benzamidine-Sepharose column, and induce plasminogen-dependent lysis of a fibrin clot.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022447      PMCID: PMC319558          DOI: 10.1073/pnas.78.6.3313

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  The N-terminal amino-acid sequences of DNA polymerase I from Escherichia coli and of the large and the small fragments obtained by a limited proteolysis.

Authors:  H Jacobsen; H Klenow; K Overgaard-Hansen
Journal:  Eur J Biochem       Date:  1974-06-15

3.  Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

Authors:  J Unkeless; K Dano; G M Kellerman; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

4.  Efficient translation of tobacco mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from commercial wheat germ.

Authors:  B E Roberts; B M Paterson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

5.  Quantitative measurement of ovalbumin messenger ribonucleic acid activity. Localization in polysomes, induction by estrogen, and effect of actinomycin D.

Authors:  R E Rhoads; G S McKnight; R T Schimke
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

6.  The isolation and characterization of plasminogen activators (urokinase) from human urine.

Authors:  W F White; G H Barlow; M M Mozen
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Immunoaffinity chromatography of proteins.

Authors:  D M Livingston
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

9.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

10.  CRYSTALLINE HUMAN UROKINASE: SOME PROPERTIES.

Authors:  A LESUK; L TERMINIELLO; J H TRAVER
Journal:  Science       Date:  1965-02-19       Impact factor: 47.728

View more
  7 in total

1.  Use of Bacillus brevis for efficient synthesis and secretion of human epidermal growth factor.

Authors:  H Yamagata; K Nakahama; Y Suzuki; A Kakinuma; N Tsukagoshi; S Udaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

2.  Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor.

Authors:  G Salerno; P Verde; M L Nolli; A Corti; H Szöts; T Meo; J Johnson; S Bullock; G Cassani; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  Streptokinase: cloning, expression, and excretion by Escherichia coli.

Authors:  H Malke; J J Ferretti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

4.  Expression of full-length human pro-urokinase in mammary glands of transgenic mice.

Authors:  Yaroslav Gursky; Robert Bibilashvili; Mikchail Minashkin; Alex Krasnov; Alex Deikin; Tatyana Ermolkevich; Andrey Popov; Lilia Verbovaya; Nicolai Rutkevich; Alexsander Shevelev; Sofia Georgieva; Sergey V Razin; Igor Goldman; Elena Sadchikova
Journal:  Transgenic Res       Date:  2009-04-25       Impact factor: 2.788

5.  Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.

Authors:  K Kaltoft; L S Nielsen; J Zeuthen; K Danø
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Synthesis of calf prochymosin (prorennin) in Escherichia coli.

Authors:  J S Emtage; S Angal; M T Doel; T J Harris; B Jenkins; G Lilley; P A Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Recombinant DNA in medicine.

Authors:  S D Cederbaum; G C Fareed; M A Lovett; L J Shapiro
Journal:  West J Med       Date:  1984-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.